Patton Fund Management Inc. Buys 16,059 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Patton Fund Management boosted its HCA stake by 2,393.3% in Q4, buying 16,059 shares to hold 16,730 shares worth $7.81 million, representing about 1.0% of the firm's portfolio and its 26th largest holding.
• HCA reported a Q4 EPS of $8.01 (vs. $7.37 estimate) and revenue of $19.51 billion (+6.7% YoY), issued FY2026 guidance of $29.10–$31.50 EPS, and raised the quarterly dividend to $0.78 ($3.12 annual).
• Company insiders have been net sellers recently — executives sold 15,214 shares (~$7.8 million) over the past three months, including SVP Christopher Wyatt (4,000 shares) and EVP Michael McAlevey (1,694 shares), while insiders now own about 1.5% of the stock.

Patton Fund Management Inc. grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2,393.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 16,730 shares of the company's stock after buying an additional 16,059 shares during the period. HCA Healthcare accounts for approximately 1.0% of Patton Fund Management Inc.'s portfolio, making the stock its 26th largest holding. Patton Fund Management Inc.'s holdings in HCA Healthcare were worth $7,811,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Assetmark Inc. grew its holdings in shares of HCA Healthcare by 89.1% during the fourth quarter. Assetmark Inc. now owns 21,548 shares of the company's stock worth $10,060,000 after purchasing an additional 10,150 shares in the last quarter. Intelligence Driven Advisers LLC grew its holdings in shares of HCA Healthcare by 24.9% during the fourth quarter. Intelligence Driven Advisers LLC now owns 602 shares of the company's stock worth $281,000 after purchasing an additional 120 shares in the last quarter. Transcend Capital Advisors LLC grew its holdings in shares of HCA Healthcare by 31.4% during the fourth quarter. Transcend Capital Advisors LLC now owns 1,996 shares of the company's stock worth $932,000 after purchasing an additional 477 shares in the last quarter. U.S. Capital Wealth Advisors LLC grew its holdings in shares of HCA Healthcare by 22.7% during the fourth quarter. U.S. Capital Wealth Advisors LLC now owns 3,769 shares of the company's stock worth $1,760,000 after purchasing an additional 697 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. boosted its stake in HCA Healthcare by 21.2% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 20,692 shares of the company's stock worth $9,660,000 after buying an additional 3,625 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the firm's stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the transaction, the senior vice president owned 44,379 shares of the company's stock, valued at approximately $22,411,395. This trade represents a 8.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Michael R. Mcalevey sold 1,694 shares of the firm's stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the transaction, the executive vice president directly owned 8,853 shares of the company's stock, valued at $4,721,924.61. This represents a 16.06% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 15,214 shares of company stock worth $7,797,595. Corporate insiders own 1.50% of the company's stock.

HCA Healthcare Stock Up 0.3%

Shares of HCA Healthcare stock opened at $497.15 on Tuesday. The company has a market cap of $111.15 billion, a PE ratio of 17.52, a P/E/G ratio of 1.52 and a beta of 1.36. The business has a 50 day moving average of $511.98 and a 200 day moving average of $482.71. HCA Healthcare, Inc. has a 52 week low of $314.43 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating analysts' consensus estimates of $7.37 by $0.64. The company had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm's revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th were issued a dividend of $0.78 per share. This is a boost from HCA Healthcare's previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Tuesday, March 17th. HCA Healthcare's dividend payout ratio is currently 10.99%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on HCA. Leerink Partners upped their target price on HCA Healthcare from $507.00 to $573.00 and gave the stock an "outperform" rating in a research note on Wednesday, January 28th. Morgan Stanley lowered HCA Healthcare from an "equal weight" rating to an "underweight" rating and set a $425.00 target price for the company. in a research note on Monday, December 15th. Oppenheimer upped their target price on HCA Healthcare from $500.00 to $540.00 and gave the stock an "outperform" rating in a research note on Wednesday, January 28th. Weiss Ratings reissued a "buy (b)" rating on shares of HCA Healthcare in a research note on Friday, March 27th. Finally, Argus increased their price objective on HCA Healthcare from $530.00 to $560.00 and gave the company a "buy" rating in a research note on Friday, February 6th. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $537.73.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.